Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Report 2026

Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Overview

• Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution market size has reached to $2.19 billion in 2025 • Expected to grow to $6.84 billion in 2030 at a compound annual growth rate (CAGR) of 25.5% • Growth Driver: Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Case Numbers • Market Trend: Next-Generation Deep Learning Platform Enhances Brain Diagnostic Accuracy • North America was the largest region in 2025.

What Is Covered Under Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?

Brain artificial intelligence (AI)-assisted diagnosis solution is a software-driven system that leverages AI algorithms to analyze brain imaging and clinical data for detecting neurological disorders. Its primary purpose is to assist clinicians in early and accurate diagnosis of conditions such as stroke, tumors, and neurodegenerative diseases, improving decision-making, treatment planning, and patient outcomes. These solutions enhance diagnostic efficiency by reducing manual interpretation time and minimizing errors. The main product types of brain artificial intelligence (AI)-assisted diagnosis solutions are hardware, software, and services. Hardware refers to the physical devices and equipment used to capture, process, and analyze neurological data, which AI algorithms then interpret to assist in brain diagnosis. These solutions utilize various technologies such as computer vision, deep learning, machine learning, and natural language, and can be deployed either through cloud or on-premise modes. These find applications in disease detection, patient monitoring, radiology analysis, and surgical robotics assistance, with end users spanning hospitals, clinics, diagnostic centers, and research institutes.

What Is The Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Growth Forecast?

The brain artificial intelligence (ai)-assisted diagnosis solution market size is expected to see exponential growth in the next few years. It will grow to $6.84 billion in 2030 at a compound annual growth rate (CAGR) of 25.5%. The growth in the forecast period can be attributed to increasing demand for early and accurate neurological diagnosis, rising investments in AI healthcare solutions, expansion of cloud-based medical platforms, growing regulatory approvals for AI diagnostics, increased integration of AI into clinical workflows. Major trends in the forecast period include increasing adoption of AI-based brain imaging analysis, rising use of deep learning algorithms in neurology, growing integration of clinical decision support systems, expansion of cloud-based diagnostic platforms, enhanced focus on early disease detection.

Global Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Segmentation

1) By Component: Hardware, Services, Software 2) By Technology: Computer Vision, Deep Learning, Machine Learning, Natural Language Processing 3) By Deployment: Cloud, On-Premise 4) By Application: Disease Detection, Patient Monitoring, Radiology Analysis, Surgical Robotics Assistance 5) By End User: Clinics, Diagnostic Centers, Hospitals, Research Institutes Subsegments: 1) By Hardware: Imaging Systems, Artificial Intelligence (AI)-Optimized Processors, Data Storage Systems, Networking And Communication Devices, Workstations And Diagnostic Terminals 2) By Services: Consulting And Integration Services, Training And Education Services, Deployment And Implementation Services, Support And Maintenance Services, Managed AI Services 3) By Software: Diagnostic Imaging Analysis Software, Machine Learning And Deep Learning Algorithms, Natural Language Processing (NLP) Tools, Clinical Decision Support Systems (CDSS), Data Management And Analytics Platforms, Cloud-Based Artificial Intelligence (AI) Platforms

What Is The Driver Of The Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the brain artificial intelligence (AI)-assisted diagnosis solution market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms, including cognitive, motor, and sensory impairments. The increasing prevalence of neurological disorders is linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of these conditions. Brain artificial intelligence (AI)-assisted diagnosis solutions aid in neurological disorders diagnosis by providing rapid, accurate, and objective analysis of brain imaging or electrical activity. They enhance clinical decision-making, support early detection of conditions such as stroke, concussion, and Alzheimer’s, and enable personalized treatment planning. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Therefore, the increasing prevalence of neurological disorders is driving the growth of the brain artificial intelligence (AI)-assisted diagnosis solutions industry.

Key Players In The Global Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market

Major companies operating in the brain artificial intelligence (AI)-assisted diagnosis solution market are Viz.ai Inc., Aidoc Medical Ltd., RapidAI Inc., Qure.ai Technologies Pvt. Ltd., Ceribell Inc., Infervision Inc., Quibim S.L., Brainomix Ltd., Hyperfine Inc., QMENTA Inc., BrainScope Company Inc., BioMind Inc., Cortechs.ai Inc., Heuron Inc., Zeto Inc., icometrix NV, Cercare Medical AB, VUNO Inc., NeuraSignal Inc., Aikenist Inc., Avicenna.AI Inc., BrainKey Technologies Inc., Deepwise AI Co. Ltd.

Global Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Trends and Insights

Major companies operating in the brain artificial intelligence (AI)-assisted diagnosis solution market are focusing on developing technologically advanced solutions, such as deep learning platforms, to enhance diagnostic accuracy, real-time analysis, and clinical decision-making. Deep learning platforms are intelligent digital systems that leverage advanced neural networks and data analytics to analyze brain electrical activity or imaging data, detect subtle abnormalities, and provide actionable insights for clinicians. For instance, in June 2025, BrainScope Company Inc., a US-based neurotechnology company, launched its next-generation deep learning platform featuring a Large Neural Model (LNM). This platform applies breakthroughs similar to large language models (LLMs) to electroencephalogram (EEG) data, enabling automated analysis without specialized quantitative EEG (qEEG) interpretation. It supports diverse brain health conditions, including concussion, stroke, and early Alzheimer's detection, by delivering rapid, objective, and clinically actionable insights. The platform also facilitates the development of refined biomarkers for precision-driven clinical trial recruitment, early diagnosis, and personalized treatment.

What Are Latest Mergers And Acquisitions In The Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?

In January 2025, SyntheticMR AB, a Sweden-based healthcare company, acquired Combinostics Oy for $5.03 million (€4.3 million). With this acquisition, SyntheticMR aims to expand its portfolio of AI-driven neuroimaging solutions, integrating Combinostics’ cNeuro platform to strengthen its capabilities in brain diagnostics and enhance its presence in the European healthcare market. Combinostics Oy is a Finland-based diagnostic company specializing in AI-assisted brain diagnosis solutions.

Regional Outlook

North America was the largest region in the brain artificial intelligence (AI)-assisted diagnosis solution market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?

The brain artificial intelligence (AI)-assisted diagnosis solution market consists of revenues earned by entities by providing services such as clinical decision support, artificial intelligence (AI)-powered brain imaging analysis, predictive analytics for disease progression, and remote diagnostics and tele-neurology. The market value includes the value of related goods sold by the service provider or included within the service offering. The brain artificial intelligence (AI)-assisted diagnosis solution market also includes sales of neuroinformatics platforms, artificial intelligence (AI)-enabled imaging devices, cloud-based analytics solutions, and artificial intelligence (AI)-integrated medical imaging hardware. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Report 2026?

The brain artificial intelligence (ai)-assisted diagnosis solution market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the brain artificial intelligence (ai)-assisted diagnosis solution industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.